D07.2 Carcinoma in situ of vagina

✓ Billable ICD-10-CM 2026
Open D07.2 in Web App →

The ICD-10-CM code for Carcinoma in situ of vagina is D07.2 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
D00-D09: In situ neoplasms (D00-D09)
Category D07
13 codes (10 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to D07.2:

  • Dysplasia › vagina › severe NEC
  • Neoplasia › intraepithelial (histologically confirmed) › vagina (histologically confirmed) (VAIN) › grade III (severe dysplasia)
Excludes1
Not coded here. These conditions should NOT be coded together with D07.2.
  • moderate dysplasia of vagina (N89.1)
  • vaginal intraepithelial neoplasia II [VIN II] (N89.1)

Inclusion Terms

  • Severe dysplasia of vagina
  • Vaginal intraepithelial neoplasia III [VAIN III]

U.S. Hospital Utilization

  • An estimated 75 U.S. inpatient stays in 2023 included D07.2 among the documented diagnoses.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial